SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma

Clinical trial NCT06122389 · RECRUITING

Trial details

NCT number: NCT06122389
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy

Start date: 2024-02-05
Primary completion: 2026-05-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.